GB0706167D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0706167D0 GB0706167D0 GBGB0706167.4A GB0706167A GB0706167D0 GB 0706167 D0 GB0706167 D0 GB 0706167D0 GB 0706167 A GB0706167 A GB 0706167A GB 0706167 D0 GB0706167 D0 GB 0706167D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0706167.4A GB0706167D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
CL200800865A CL2008000865A1 (en) | 2007-03-29 | 2008-03-26 | COMPOUNDS DERIVED FROM BENZIMIDAZOL-2-ONA; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A PSYCHOTIC DISORDER OR A COGNITIVE DETERIORATION. |
ARP080101269A AR065864A1 (en) | 2007-03-29 | 2008-03-27 | COMPOSITE OF OXI-CICLOHEXIL-PIPERIDINIL-DIHIDRO-BENZIMIDAZOL-2-ONA PHARMACEUTICAL COMPOSITION THAT IS INCLUDED IN ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT AND INTERMEDIARY COMPOUNDS FOR PREPARATION |
TW097110899A TW200901979A (en) | 2007-03-29 | 2008-03-27 | Compounds which have activity at M1receptor and their uses in medicine |
PCT/EP2008/053601 WO2008119721A1 (en) | 2007-03-29 | 2008-03-27 | Compounds which have activity at m1 receptor and their uses in medicine |
PE2008000559A PE20090553A1 (en) | 2007-03-29 | 2008-03-27 | BENZHIMIDAZOLONE DERIVED COMPOUNDS THAT HAVE ACTIVITY IN THE M1 RECEPTOR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0706167.4A GB0706167D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0706167D0 true GB0706167D0 (en) | 2007-05-09 |
Family
ID=38050489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0706167.4A Ceased GB0706167D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR065864A1 (en) |
CL (1) | CL2008000865A1 (en) |
GB (1) | GB0706167D0 (en) |
PE (1) | PE20090553A1 (en) |
TW (1) | TW200901979A (en) |
WO (1) | WO2008119721A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288412B2 (en) | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Compounds which have activity at M1 receptor and their uses in medicine |
WO2007036711A1 (en) | 2005-09-30 | 2007-04-05 | Glaxo Group Limited | BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR |
CA2624504C (en) | 2005-09-30 | 2014-07-08 | Glaxo Group Limited | Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine |
EP2194982A1 (en) | 2007-09-20 | 2010-06-16 | Glaxo Group Limited | Compounds which have activity at m1 receptor and their uses in medicine |
GB0718415D0 (en) | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU701127B2 (en) * | 1994-10-27 | 1999-01-21 | Merck & Co., Inc. | Muscarine antagonists |
AU7478396A (en) * | 1995-10-31 | 1997-05-22 | Merck & Co., Inc. | Muscarine agonists |
EP1221443B1 (en) * | 1999-10-13 | 2004-09-01 | Banyu Pharmaceutical Co., Ltd. | Substituted imidazolidinone derivatives |
WO2003105781A2 (en) * | 2002-06-17 | 2003-12-24 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
GB0605785D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
GB0605784D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
GB0605786D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
-
2007
- 2007-03-29 GB GBGB0706167.4A patent/GB0706167D0/en not_active Ceased
-
2008
- 2008-03-26 CL CL200800865A patent/CL2008000865A1/en unknown
- 2008-03-27 PE PE2008000559A patent/PE20090553A1/en not_active Application Discontinuation
- 2008-03-27 WO PCT/EP2008/053601 patent/WO2008119721A1/en active Application Filing
- 2008-03-27 TW TW097110899A patent/TW200901979A/en unknown
- 2008-03-27 AR ARP080101269A patent/AR065864A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2008000865A1 (en) | 2008-10-03 |
TW200901979A (en) | 2009-01-16 |
WO2008119721A1 (en) | 2008-10-09 |
PE20090553A1 (en) | 2009-06-06 |
AR065864A1 (en) | 2009-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706793D0 (en) | Compounds | |
GB0704407D0 (en) | Compounds | |
GB0704394D0 (en) | Compounds | |
GB0705672D0 (en) | Compounds | |
GB0706173D0 (en) | Compounds | |
GB0707092D0 (en) | Compounds | |
GB0706188D0 (en) | Compounds | |
GB0706168D0 (en) | Compounds | |
GB0706165D0 (en) | Compounds | |
GB0707034D0 (en) | Compounds | |
GB0706187D0 (en) | Compounds | |
GB0706167D0 (en) | Compounds | |
GB0706189D0 (en) | Compounds | |
GB0706174D0 (en) | Compounds | |
GB0706170D0 (en) | Compounds | |
GB0706164D0 (en) | Compounds | |
GB0706190D0 (en) | Compounds | |
GB0704939D0 (en) | Compounds | |
GB0703756D0 (en) | Compounds | |
GB0701985D0 (en) | Compounds | |
GB0703906D0 (en) | Compounds | |
GB0701984D0 (en) | Compounds | |
GB0703067D0 (en) | Compounds | |
GB0702973D0 (en) | Compounds | |
GB0702961D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |